Fauzia Nomani ( Stroke Service and Vascular Fellowship Program, International Cerebrovascular Translational Clinical Research Training Program (Fogarty International Center and National Institute of Neurologic Disorders and Stroke), Aga Khan University Hospital, Karachi, Pakistan. )
Ayeesha Kamran Kamal ( Stroke Service and Vascular Fellowship Program, International Cerebrovascular Translational Clinical Research Training Program (Fogarty International Center and National Institute of Neurologic Disorders and Stroke), Aga Khan University Hospital, Karachi, Pakistan. )
Aspirin and clopidogrel are the two effective anti platelet drugs which are used in loading doses in other vascular events like cardiac to prevent further deterioration. The value of this approach for the brain is not known.
What is the study design?
This pilot study was conducted to assess the safety and efficacy of the double anti platelet agents in loading doses in patient with acute ischaemic stroke presenting within 36 hours of onset of symptoms.
Who were the patients?
Forty patients were enrolled from a single stroke center in six months. All the patients were diagnosed to have stroke or TIA by examination from a stroke specialist fitting their inclusion criteria. Primary safety aim was symptomatic haemorrhage with a secondary end point of neurological detoriation.
What were the results?
The dose appeared to be safe as no acute intracranial haemorrhages were detected with no mortality. Only a single symptomatic intracranial haemorrhage 2.5% was detected 43days post treatment. None of the patients experienced neurological detoriation within 24hrs and 97% had no detoriation by 7 days of treatment. Treatment was compared with matched control patients.
The author concluded that high loading doses of two antiplatelet agents were effective in the treatment of patient with acute ischaemic stroke within 36hrs of onset.
Why is this study important?
This study provides successful ground for the safety and efficacy of these drugs for future studies in the treatment of acute ischaemic stroke not fulfilling the criteria of acute revascularization.In Pakistan cost of r tPA limits revascularization therapy in many of eligible patients with stroke. This trial has shown promising result for loading doses of aspirin and Clopidogrel safety, and we should await efficacy results before we start loading 2 agents for every patient. However, this is a promising alternative for a resource strapped region.
Acknowledgement and Disclosure Statement
The International Cerebrovascular Translational Clinical Research and Training Program (ICT_CRT) at the Aga Khan University is supported by funds from the Award Number D43TW008660 from the Fogarty International Center and the National Institute of Neurologic Disorders and Stroke. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Fogarty International Center or the National Institutes of Health.
1. Meyer DM, Albright KC, Allison TA, Grotta JC. LOAD: a pilot study of the safety of loading of aspirin and clopidogrel in acute ischemic stroke and transient ischemic attack. J Stroke Cerebrovasc Dis 2008; 17: 26-9.